<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 12 Feb 2021 11:33:22 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>靶向实体瘤，TCR疗法可在癌症治疗中发挥重要作用丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/UcoO2XRbA8-IsARC4FqD5A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItgIlobAqsJm1bvcZO3JJexwjKebY7seIiajFb2NAkJOgnyIpdRicewmFgp27UialCN4cpCeYZovS21A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>自体和同种异体细胞产品并存，在疾病和患者亚群之间差异使用]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:17:45 +0800</pubDate></item><item><title>康威生物获得UbiVac免疫疗法癌症疫苗DPV-001大中华地区独家授权丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/pctD8g9cfF-q3FxfVrr_Hg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItr4MA9FQQvftJKLeY1pPZichkGsCibfvJc38uTceKxuZrOrnveQLrUdzJxyA9CAGgERickpTM7AuNfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>能够显著增强晚期癌症患者的抗肿瘤免疫力]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:17:45 +0800</pubDate></item><item><title>全球新冠感染率呈下降趋势！一窥接种疫苗后的“真实世界”丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/v3LZ3xl4eK03jwjxmu-nCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvCoeVaDbJILnDmWhbq5pibFCfDAyHk6Z7NnHTAGMTUom6xyDmwpXYYB5NtWJ2j42npQ4Oibiczolahg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全球多少人已接种疫苗？疫苗起效了吗？]]></content:encoded><pubDate>Wed, 10 Feb 2021 22:28:33 +0800</pubDate></item><item><title>Nature子刊：重磅数据！AAV基因治疗的临床试验分析与趋势丨医麦新观察</title><link>https://mp.weixin.qq.com/s/fd0AoQhleEQdJMN6foYTJg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvCoeVaDbJILnDmWhbq5pibF0o1uQmBHBx6wZa1lGT0Vh4AjKAudxlwicQW8ibtCLBUB2Egu1PLymWibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>20多年，3000多名接受AAV基因治疗的患者]]></content:encoded><pubDate>Wed, 10 Feb 2021 22:28:33 +0800</pubDate></item><item><title>CAR-T全球市场持续上新，国内首款产品上市之前的商业布局成为焦点丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/rB7NcRR8OUhujYtJfyRYvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyriaklQ2JakgxHAVaiavoOLF6WuCzWSePqoJcictauicTmSCHYr667Su3LOg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>关于定价、支付以及终端销售模式搭建的讨论]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>药融资 | 卡替医疗完成新一轮亿元级融资，持续领跑TIL疗法赛道</title><link>https://mp.weixin.qq.com/s/oo92cgLLPnnMTFzpVomavg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyrWOKZWckL2jiad1xDib6ibpWvYKUlCJmKRNCeoT0dr0Co3EtZOHSNsrYUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本次融资将用于支持卡替医疗公司的“超强型TIL”细胞治疗产品完成IND申报。]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>国内首例，国健呈诺异体“现货型”CAR-NK细胞注射液治疗实体瘤临床申请获国家药监局受理丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Q56E3YB8V12ejnJ5_nGI4g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyrNkr2iajexKWREqwiaQX3cLmUxcnq5O1AQUmWywGIB2DUfTxKXCRVaUtA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>针对晚期上皮性卵巢癌，靶向间皮素]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>加速生物药的研发和产业化进程，澳斯康生物制药与复宏汉霖达成战略合作意向丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/qtI6J53Tg-TP7kwFYxpeyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnesp3wZ83LhSPvxetic4srQRmu5LtRJo3UJMaicIHPTBIWYWqHP4dDxiaRQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一起为全球患者提供质高价优的生物药物]]></content:encoded><pubDate>Tue, 09 Feb 2021 11:32:43 +0800</pubDate></item><item><title>重磅！国健呈诺异体外周血来源的现货型CAR-NK细胞产品临床申请获国家药监局受理丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/xM2Pmr5eZCNM6wacgwRCfQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItr4MA9FQQvftJKLeY1pPZiciaZVibLdvLbXEuEdb1sS9LVpQaicrIYsibttPWian7PC0shy9icxicKybmhuA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CDE受理的首个用于实体瘤治疗的CAR-NK细胞产品]]></content:encoded><pubDate>Tue, 09 Feb 2021 11:32:43 +0800</pubDate></item><item><title>i-GONAD技术，开启原位基因编辑胚胎的新征程丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/SWxdncTmVOkRaQhJ6guu3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnes93SavMKetdA9wyx9ibyGgawEU2gqbUzzPSbyBWzpiaNUAOKuDN1vxsQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>i-GONAD不仅可替代受精卵显微注射，在基因编辑效率上也可达到显微注射水平。]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>罗氏/Spark公布A型血友病基因疗法的最新临床数据丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/tOSv6XaPS4vOt8JCRDNPCQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRne5ChaYjHKCcTLdUYAAnIhcZvqsCNoBN8sYicwGGzSwS6lTbXZqqyldCg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>A型血友病基因疗法现况]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>强强联合！拜耳联合CureVac生产新冠疫苗丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/BQrzTrLdSlvZjqMY6Hm0Fg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneUvmmL06rfCDicdIkEQ3GqdvDCAUZvG9GtnLbprQbPsVfHEMNXPpzjXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>急需扩大的新冠疫苗产能]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>国内基因和细胞治疗蓬勃发展，CDMO业务有望进一步扩展丨峰客创见</title><link>https://mp.weixin.qq.com/s/vJ2s5D1yqkwkJhWWPDNIIA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneIicpzGNQETkS6UR1Nk7Zru2ya1eSZXxyc5JZOWooppGKica4EibzkoOMQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 创见专栏]]></content:encoded><pubDate>Sun, 07 Feb 2021 21:45:25 +0800</pubDate></item><item><title>里程碑达成丨金斯瑞蓬勃生物助力庄亚生物生产的200L GMP凝血因子VIII完成交付</title><link>https://mp.weixin.qq.com/s/L37cqMqL55EybGA_E2rV1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnefoUZtn6QgT3a7Qu1xZctd2OVXkIJxB73k4Rujnz1gkY9xiaj9niaWddg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>内容涵盖了单克隆筛选、工艺开发、分析方法开发及GMP生产。]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>药融资丨原能生物完成3.4亿元战略融资，推进生物智能装备制造及完善服务体系建设</title><link>https://mp.weixin.qq.com/s/8Z5ngZe4ztZ2DYkYSh_FNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneXfghqoJdxICcDUBaJ0YfqA9tM4MPkuevwrwLwgUIDib4svvOgqibX0fg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>原能生物启动全球化销售渠道合作及服务网络建设，将这一原创性且填补行业空白的高标准、智能化装备加快推进市场。]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>西湖生物医药与南京维立志博达成合作，开发多款携带抗体药物的工程化红细胞丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/z96P-d0WnlFsQzwjCCSUeA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneXzV9MOBRzkfGcViaKFRFlwZ2A3E7PDxp32b95GDXicoxYI3p3jibcKcEA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>第四款CAR-T获得FDA批准上市！BMS重金收购而来的CAR-T细胞产品终于成功上市！丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/2ifICu304kllgu1RHaRZXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRneElNKMqzHFFV3AEeibc1X3FxWR81240HdheEa1QibUg55K9vkzW9icdJlg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全球CAR-T市场又迎来一位重量级玩家！]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:09:18 +0800</pubDate></item><item><title>抗独特型抗体在抗体药物研发过程中发挥重要作用，不得不看的《抗独特型抗体开发实用手册》丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Iyw9o-zZEKbwHyIwm-h2fg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkpp0t4zDaEB2Z2ibM3e9wXRO1zqVyuFUwhVKHvQ4FPSgReUicb8A8aDPXuw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>热门手册，一键下载]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item><item><title>吉利德2020财报：瑞德西韦为吉利德带来巨大现金流，CAR-T和ADC药物是吉利德的未来主要驱动力丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/-QxF_egRoZc5ll_fytcw9w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkppCZErFvXzgR0LX0CoYuQxAAmfojMaQibPL04mLvMLzibwAujBuiaHx4uJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T全球市场突破10亿美元]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item><item><title>早期临床数据显示iNKT治疗重度新冠肺炎有效，75%的患者成功拔管出院丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Sxg-u-oKvI-aowVXUz1qdA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItZhnbVZlJpG0UXjU3UAkppEvPqpgPQyY6bPhDEMdJWHArJicFk5Kv7YaTJ0lIpa4CsLMeMFiczgF1Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>细胞治疗新冠肺炎]]></content:encoded><pubDate>Fri, 05 Feb 2021 18:22:13 +0800</pubDate></item></channel></rss>